In vivo and In Vitro Antitumor Effects of a Staphylococcal Enterotoxin A Mutant (SEA-H61D)

REFERENCES

• Matthew, D.B.; Acharya, K.R. Superantigens: structure-function relationships. Int J Med Microbiol 2004, 293, 529–537.
   PubMed Web of Science ®Google Scholar
• Dohlsten, M.; Sundstedt, A.; Bjorklund, M.; Hedlund, G.; Kalland, T. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 1993, 54, 482–488.
   Google Scholar
• Lando, P.A.; Hedlund, G.; Dohlsten, M.; Kalland, T. Bacterial superantigens as antitumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother 1991, 33, 231–237.
   PubMed Web of Science ®Google Scholar
• Perabo, F.G.; Willert, P.L.; Wirger, A.; Schmidt, D.H.; Wardelmann, E.; Sitzia, M.; Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer. Int J Cancer 2005, 115, 591–598.
   PubMed Web of Science ®Google Scholar
• Litton, M.J.; Dohlsten, M.; Lando, P.A.; Kalland, T.; Ohlsson, L.; Andersson, J. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. Eur J Immunol 1996, 26, 1–9.
   PubMed Web of Science ®Google Scholar
• Litton, M.J.; Dohlsten, M.; Rosendahl, A.; Ohlsson, L.; Sogaard, M.; Andersson, J. The distinct role of CD4+ and CD8+ T-cells during the antitumour effects of targeted superantigens. Br J Cancer 1999, 81, 359–366.
   PubMed Web of Science ®Google Scholar
• Ochi, A.; Migita, K.; Xu, J.; Siminovitch, K. In vivo tumor immunotherapy by a bacterial superantigen. J Immunol 1993, 151, 3180–3186.
   PubMed Web of Science ®Google Scholar
• Penna, C.; Dean, P.A.; Nelson, H. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res 1994, 54, 2738–2743.
   PubMed Web of Science ®Google Scholar
• Forsberg, G.; Ohlsson, L.; Brodin, T.; Bjork, P.; Lando, P.A.; Shaw, D.; Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen. Br J Cancer 2001, 85, 129–136.
   PubMed Web of Science ®Google Scholar
• Giantonio, B.J.; Alpaugh, R.K.; Schultz, J.; McAleer, C.; Newton, D.W.; Shannon, B.; Superantigen-based immunotherapy: a phase-I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J Clin Oncol 1997, 15, 1994–2007.
   PubMed Web of Science ®Google Scholar
• Alpaugh, R.K.; Schultz, J.; McAleer, C.; Giantonio, B.J.; Persson, R.; Burnite, M.; Superantigen-targeted therapy: phase-I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies. Clin Cancer Res 1998, 4, 1903–1914.
   PubMed Web of Science ®Google Scholar
• Nielsen, S.E.; Zeuthen, J.; Lund, B.; Persson, B.; Alenfall, J.; Hansen, H.H. Phase-I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma. J Immunother 2000, 23, 146–153.
   PubMed Web of Science ®Google Scholar
• Pulaski, B.A.; Terman, D.S.; Khan, S.; Muller, E.; Ostrand-Rosenberg, S. Cooperativity of staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res 2000, 60, 2710–2715.
   PubMed Web of Science ®Google Scholar
• Reid, I.M.; Lundy, J.K.; Donohue, J.H. The bispecific antibody 500A2 x 96.5 targets T-lymphocytes activated in vivo with staphylococcal enterotoxin B (SEB) against CL62 melanoma cells in vitro. Surg Oncol 1994, 3, 279–285.
   PubMed Web of Science ®Google Scholar
• Shimizu, M.; Yamamoto, A.; Nakano, H.; Matsuzawa, A. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells. Cancer Res 1996, 56, 3731–3736.
   PubMed Web of Science ®Google Scholar
• Kominsky, S.L.; Torres, B.A.; Hobeika, A.C.; Lake, F.A.; Johnson, H.M. Superantigen-enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer. Int J Cancer 2001, 94, 834–841.
   PubMed Web of Science ®Google Scholar
• Ren, S.; Terman, D.S.; Bohach, G.; Silvers, A.; Hansen, C.; Colt, H.; Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 2004, 126, 1529–1539.
   PubMed Web of Science ®Google Scholar
• Hongtu, G.; Jun, D. Clinical observation of consecutive chemotherapy aided by HAS on 61 NSCLC. Chin J Clin Oncol 2004, 27, 81–83.
   Google Scholar
• Youming, P.; Tangying, X.; Tiecheng, P.; Zhi, Z.; Qinzi, X. Clinical observation of highly agglutinative staphylococc combined with cisplatin in treatment of malignant hydrothorax. China J Mod Med 2006, 16, 410–412.
   Google Scholar
• Torres, B.A.; Kominsky, S.; Perrin, G.Q.; Hobeika, A.C.; Johnson, H.M. Superantigens: the good, the bad, and the ugly. Exp Biol Med (Maywood, N.J) 2001, 226, 164–176.
   PubMed Web of Science ®Google Scholar
• Hoffman, M.; Tremaine, M.; Mansfield, J.; Betley, M. Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect Immun 1996, 64, 885–890.
   PubMed Web of Science ®Google Scholar
• Reck, B.; Scheuber, P.H.; Londong, W.; Sailer-Kramer, B.; Bartsch, K.; Hammer, D.K. Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc Natl Acad Sci USA 1988, 85, 3170–3174.
   PubMed Web of Science ®Google Scholar
• Harris, T.O.; Betley, M.J. Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect Immun 1995, 63, 2133–2140.
   PubMed Web of Science ®Google Scholar
• Harris, T.O.; Grossman, D.; Kappler, J.W.; Marrack, P.; Rich, R.R.; Betley, M.J. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun 1993, 61, 3175–3183.
   PubMed Web of Science ®Google Scholar
• Jiang, Y.Q.; Zheng, Y.; Ning, B.A.; Ma, R.; Wang, J.L.; Gao, Z.X. Cloning, high-level expression, and purification of Staphylococcal Enterotoxin A. J Microbiol 2002, 22, 5–6.
   Google Scholar
• Jiang, Y.Q.; Zheng, Y.; Ning, B.A.; Ma, R.; Li, H.P.; Wang, J.L. Study on the molecular design, high-level expression, and activity of mutant staphylococcal enterotoxin B. Lett Biotechnol 2002, 13, 341–343.
   Google Scholar
• Hao, H.J.; Jiang, Y.Q.; Zheng, Y.L.; Ma, R.; Yu, D.W. Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety. Biochimie 2005, 87, 661–667.
   PubMed Web of Science ®Google Scholar
• Parrizas, M.; Gazit, A.; Levitzki, A.; Wertheimer, E.; LeRoith, D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinol 1997, 138, 1427–1433.
   PubMed Web of Science ®Google Scholar
• Lu, D.Y.; Xu, B.; Ding, J. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacol 2004, 4, 32.
   PubMedGoogle Scholar
• Terman, D.S.; Young, J.B.; Shearer, W.T.; Ayus, C.; Lehane, D.; Mattioli, C.; Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. New Engl J Med 1981, 305, 1195–1200.
   PubMed Web of Science ®Google Scholar
• Wang, D.G.; Liu, J.J.; Qin, X.L. Curative effect of highly agglutinative staphylouoccin plus radiotherapy in treatment of the cervical lymph node metaststic carcinoma. J Med Forum 2004, 25, 17–18.
   Google Scholar
• Rui, H.S.; Wei, M.L. staphylococc in aureus filtrate preparation in the treatment of refractory malignant pleural effusions. Acta Academiae Medicinae Militaris Tertiae 2005, 27, 2096.
   Google Scholar
• Hedlund, G.; Dohlsten, M.; Lando, P.A.; Kalland, T. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells. Cell Immunol 1990, 129, 426–434.
   PubMed Web of Science ®Google Scholar
• Herrmann, T.; Romero, P.; Sartoris, S.; Paiola, F.; Accolla, R.S.; Maryanski, J.L.; Staphylococcal enterotoxin-dependent lysis of MHC class-II negative target cells by cytolytic T lymphocytes. J Immunol 1991, 146, 2504–2512.
   PubMed Web of Science ®Google Scholar
• Rellahan, B.L.; Jones, L.A.; Kruisbeek, A.M.; Fry, A.M.; Matis, L.A. In vivo induction of anergy in peripheral V beta 8+ T-cells by staphylococcal enterotoxin B. J Exp Med 1990, 172, 1091–1100.
   PubMed Web of Science ®Google Scholar